Haemonetics Corporation (HAE)
Debt-to-equity ratio
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 797,564 | 856,849 | 748,662 | 751,381 | 754,102 | 756,826 | 759,552 | 763,141 | 559,441 | 633,118 | 698,043 | 767,345 | 690,592 | 292,721 | 297,016 | 296,893 | 305,513 | 309,738 | 313,984 | 318,144 |
Total stockholders’ equity | US$ in thousands | 959,959 | 943,319 | 893,660 | 864,616 | 817,997 | 775,979 | 729,009 | 770,423 | 749,424 | 730,775 | 698,549 | 677,080 | 731,670 | 719,152 | 667,923 | 608,569 | 587,109 | 574,580 | 583,754 | 590,966 |
Debt-to-equity ratio | 0.83 | 0.91 | 0.84 | 0.87 | 0.92 | 0.98 | 1.04 | 0.99 | 0.75 | 0.87 | 1.00 | 1.13 | 0.94 | 0.41 | 0.44 | 0.49 | 0.52 | 0.54 | 0.54 | 0.54 |
March 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $797,564K ÷ $959,959K
= 0.83
The debt-to-equity ratio of Haemonetics Corporation has fluctuated over the past years, indicating varying levels of leverage and financial risk. As of March 31, 2024, the debt-to-equity ratio stands at 0.83, suggesting that the company has a lower level of debt relative to equity. This indicates a conservative capital structure where equity financing plays a significant role.
Looking at historical trends, the ratio has shown some volatility, reaching a peak of 1.13 in December 2021 and a low of 0.41 in December 2020. The increasing trend from 2020 to 2021 indicates a higher reliance on debt for financing, potentially to fund expansion or acquisitions. However, the ratio has since decreased, pointing towards a move towards a more balanced capital structure.
Overall, analyzing the debt-to-equity ratio provides insights into Haemonetics Corporation's capital structure and financial risk management strategies. A lower ratio generally signifies a lower financial risk, while a higher ratio may indicate higher leverage and potential risk. Additionally, fluctuations in the ratio over time can reflect changes in the company's financing decisions and business operations. Monitoring this ratio is crucial for understanding the company's overall financial health and its ability to meet its debt obligations.
Peer comparison
Mar 31, 2024